Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2013 Jun;5(6):799-801.
doi: 10.1002/emmm.201302781. Epub 2013 May 13.

Farber disease: understanding a fatal childhood disorder and dissecting ceramide biology

Mark S Sands  1
Affiliations
Comment

Farber disease: understanding a fatal childhood disorder and dissecting ceramide biology

Mark S Sands. EMBO Mol Med. 2013 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1. Acid ceramidase and ceramide actions
Ceramide is a lipid that is sequentially synthesized through several reactions starting with palmitoyl-CoA and l-serine. Ceramide is central to the further synthesis of several key membrane lipids such as sphingomyelin and the glycospohingolipids, galactosylceramide and glucosylceramide. Ceramide has also been shown to be directly involved in a number of biological processes, including lipid raft integrity, inflammation, apoptosis, metabolic syndrome and differentiation, just to name a few. Acid ceramidase (ACDase) is a soluble lysosomal enzyme responsible for the breakdown of ceramide to sphingosine and fatty acid. A deficiency in ACDase activity leads to the accumulation of ceramide in many tissues, the hallmark of Farber disease. Acid ceramidase has also been shown to be involved in the resistance of certain tumor cells to chemotherapeutic agents and has been identified as a tumor marker in other malignancies.
See this image and copyright information in PMC

Comment on

  • Systemic ceramide accumulation leads to severe and varied pathological consequences.
    Alayoubi AM, Wang JC, Au BC, Carpentier S, Garcia V, Dworski S, El-Ghamrasni S, Kirouac KN, Exertier MJ, Xiong ZJ, Privé GG, Simonaro CM, Casas J, Fabrias G, Schuchman EH, Turner PV, Hakem R, Levade T, Medin JA. Alayoubi AM, et al. EMBO Mol Med. 2013 Jun;5(6):827-42. doi: 10.1002/emmm.201202301. Epub 2013 May 16. EMBO Mol Med. 2013. PMID: 23681708 Free PMC article.

References

    1. Alayoubi AM, Wang JCM, Au BCY, Carpentier S, Garcia V, Dworski S, Ghamrasni SE, Kirouac KN, Exertier J, Xiong ZJ, et al. Systemic ceramide accumulation leads to severe and varied pathological consequences. EMBO Mol Med. 2013 DOI: . - DOI - PMC - PubMed
    1. Bieberich E. It's a lipid world: bioactive lipid metabolism and signaling in neural stem cell differentiation. Neurochem Res. 2012;37:1208–1229. - PMC - PubMed
    1. Eliyahu E, Shtraizent N, Shalgi R, Schuchman EH. Construction of conditional ceramidase knockout mice and in vivo effects on oocyte development and fertility. Cell Physiol Biochem. 2012;30:735–748. - PMC - PubMed
    1. Farber S, Cohen J, Uzman LL. Lipogranulomatosis: a new lipo-glyco-protein “storage” disease. J Mt Sinai Hosp. 1957;24:816–837. - PubMed
    1. Hawkins-Salsbury JA, Reddy AS, Sands MS. Combination therapy for lysosomal storage diseases: is the whole greater than the sum of its parts. Hum Mol Genet. 2011;20:R54–R60. - PMC - PubMed

Publication types